Sen. Ron Johnson (R-WI) plans to ask the Senate to pass through unanimous consent next week his bill barring the federal government from interfering with states' Right To Try laws and providing liability shields to drug makers that provide patients experimental drugs. But an FDA official told lawmakers Thursday (Sept. 22) that a better path forward would be to make pharmaceutical companies' policies more transparent under the current expanded access program, as called for in the House-passed 21st Century Cures...